Table 1.
Synthesis and SAR of substituted 3-arylindazoles.
![]() | |||||||
|---|---|---|---|---|---|---|---|
| Compound | R1 | R2 | MEK4-p38, IC50, µM [95% CI] | Compound | R1 | R2 | MEK4-p38, IC50, µM [95% CI] |
| 6a | H | 3’-CO2H | 0.64 [0.53, 0.77] | 6q | 5-CH3 | 4’-OH | 0.59 [0.46, 0.75] |
| 6bb | 4-CH3 | 4’-OH | 4.0 [3.3, 4.8] | 6r | 5-CH3 | 4’-CONH2 | 0.56 [0.40, 0.77] |
| 6c | 4-Cl | 3’,4’-(OCH2O) | 4.5 [3.9, 5.2] | 6s | 5-CH3 | 4’-CO2H | 0.15 [0.10, 0.23] |
| 6d | 4-Cl | 4’-CONH2 | 4.4 [3.9, 5.0] | 6t | 5-CH3 | 3’-pyridyl | 1.6 [1.1, 2.3] |
| 6e | 4-Cl | 3’-pyridyl | > 22 | 6u | 5-CH3 | 3’-CH2OH | 1.4 [1.2, 1.8] |
| 6f | 4-Cl | 3’-CH2OH | 7.2 [6.0, 8.6] | 6v | 5-CH3 | 3’-CONH2 | 0.97 [0.74, 1.3] |
| 6g | 4-Cl | 3’-C(CH3)OH | > 22 | 6w | 5-CH3 | 4’-CH2OH | 1.3 [1.1, 1.5] |
| 6h | 4-Cl | 3’-CONH2 | 1.3 [1.0, 1.6] | 6x | 6-CF3 | 3’,4’-(OCH2O) | 6.1 [4.9, 7.7] |
| 6i | 4-Cl | 4’-CH2OH | 8.1 [7.2, 9.1] | 6y | 6-CF3 | 4’-CO2CH3 | > 20 |
| 6j | 5-CF3 | 4’-OH | 0.76 [0.67, 0.86] | 6z | 6-CF3 | 4’-CO2H | 0.72 [0.56, 0.92] |
| 6kc | 5-CF3 | 4’-OH | > 20 | 6aa | 6-Cl | 3’,4’-(OCH2O) | 0.46 [0.30, 0.71] |
| 6lc | 5-CF3 | 3’-CONH2 | 9.9 [7.3, 14] | 6bb | 6-Cl | 4’-CO2CH3 | 2.2 [1.7, 2.9] |
| 6m | 5-CF3 | 4’-CONH2 | 1.1 [0.99, 1.3] | 6cc | 6-Cl | 4’-CO2H | 0.12 [0.10, 0.14] |
| 6n | 5-CF3 | 4’-CO2H | 0.47 [0.39, 0.55] | 6dd | 6-F | 4’-CO2CH3 | 0.42 [0.35, 0.51] |
| 6ob | 5-CH3 | 3’-CH2OH, 4’-F | 1.0 [0.69, 1.5] | 6ee | 6-F | 3’,4’-(OCH2O) | 0.063 [0.029, 0.14] |
| 6p | 5-CH3 | 3’,4’-(OCH2O) | 0.41 [0.36, 0.48] | 6ff | 6-F | 4’-CO2H | 0.041 [0.034, 0.049] |
Reagents and Conditions: (a) i. NaOH, I2, MeOH, rt, 24 h, 90–95%; ii. Boc2O, rt, 16 h.; (b) Ar-B(OH)2, PdCl2(dppf)·DCM, K3PO4, H2O, 1,4-Dioxane, 90 °C, 1.5 h., 50–70%.
Compounds were purchased from ChemBridge.
Compound has a Boc-group on the indazole N-1 position.
